IMNM
Price
$5.91
Change
-$0.33 (-5.29%)
Updated
Apr 4, 02:41 PM (EDT)
Capitalization
542.57M
34 days until earnings call
MGX
Price
$1.38
Change
+$0.12 (+9.52%)
Updated
Apr 4, 02:44 PM (EDT)
Capitalization
47.66M
46 days until earnings call
Ad is loading...

IMNM vs MGX

Header iconIMNM vs MGX Comparison
Open Charts IMNM vs MGXBanner chart's image
Immunome
Price$5.91
Change-$0.33 (-5.29%)
Volume$580
Capitalization542.57M
Metagenomi
Price$1.38
Change+$0.12 (+9.52%)
Volume$2.43K
Capitalization47.66M
IMNM vs MGX Comparison Chart
Loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMNM vs. MGX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMNM is a Hold and MGX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 04, 2025
Stock price -- (IMNM: $6.24 vs. MGX: $1.26)
Brand notoriety: IMNM and MGX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMNM: 93% vs. MGX: 84%
Market capitalization -- IMNM: $542.57M vs. MGX: $47.66M
IMNM [@Biotechnology] is valued at $542.57M. MGX’s [@Biotechnology] market capitalization is $47.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.64B to $0. The average market capitalization across the [@Biotechnology] industry is $2.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMNM’s FA Score shows that 0 FA rating(s) are green whileMGX’s FA Score has 1 green FA rating(s).

  • IMNM’s FA Score: 0 green, 5 red.
  • MGX’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMNM and MGX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMNM’s TA Score shows that 4 TA indicator(s) are bullish while MGX’s TA Score has 3 bullish TA indicator(s).

  • IMNM’s TA Score: 4 bullish, 4 bearish.
  • MGX’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, IMNM is a better buy in the short-term than MGX.

Price Growth

IMNM (@Biotechnology) experienced а -14.29% price change this week, while MGX (@Biotechnology) price change was -18.18% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.30%. For the same industry, the average monthly price growth was -17.15%, and the average quarterly price growth was -18.93%.

Reported Earning Dates

IMNM is expected to report earnings on May 08, 2025.

MGX is expected to report earnings on May 20, 2025.

Industries' Descriptions

@Biotechnology (-11.30% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMNM($543M) has a higher market cap than MGX($47.7M). IMNM YTD gains are higher at: -41.243 vs. MGX (-65.097). MGX has higher annual earnings (EBITDA): -65.06M vs. IMNM (-109.95M). MGX has more cash in the bank: 275M vs. IMNM (240M). IMNM has less debt than MGX: IMNM (2.72M) vs MGX (46.1M). MGX has higher revenues than IMNM: MGX (55.1M) vs IMNM (10.1M).
IMNMMGXIMNM / MGX
Capitalization543M47.7M1,138%
EBITDA-109.95M-65.06M169%
Gain YTD-41.243-65.09763%
P/E RatioN/AN/A-
Revenue10.1M55.1M18%
Total Cash240M275M87%
Total Debt2.72M46.1M6%
TECHNICAL ANALYSIS
Technical Analysis
IMNMMGX
RSI
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
Aroon
ODDS (%)
Bearish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
IMNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MGX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RYIAX117.89N/A
N/A
Rydex Internet H
BUFDX31.88N/A
N/A
Buffalo Growth & Income
JEEIX16.06N/A
N/A
JHancock Infrastructure I
VGIFX85.38N/A
N/A
JPMorgan US Value R5
WSMRX25.49N/A
N/A
William Blair Small-Mid Cap Growth R6

IMNM and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMNM has been loosely correlated with KYMR. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMNM jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMNM
1D Price
Change %
IMNM100%
-7.00%
KYMR - IMNM
52%
Loosely correlated
-10.13%
IDYA - IMNM
50%
Loosely correlated
-4.77%
BEAM - IMNM
50%
Loosely correlated
-10.93%
RXRX - IMNM
49%
Loosely correlated
-9.07%
ADVM - IMNM
49%
Loosely correlated
-7.51%
More

MGX and

Correlation & Price change

A.I.dvisor indicates that over the last year, MGX has been loosely correlated with KOD. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if MGX jumps, then KOD could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGX
1D Price
Change %
MGX100%
-5.26%
KOD - MGX
40%
Loosely correlated
-10.11%
CVM - MGX
37%
Loosely correlated
-5.47%
VERV - MGX
35%
Loosely correlated
-1.66%
IMNM - MGX
32%
Poorly correlated
-7.00%
CDXS - MGX
32%
Poorly correlated
-8.03%
More